ABT
HEALTHCAREAbbott Laboratories
$86.30-0.87 (-1.00%)PRE
Live · NYSE · May 9, Close
AI Insight
What's Moving ABT Today?
No stock-specific AI insight has been generated for ABT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$86.15$136.28
$86.30
Fundamentals
Market Cap$150.3B
P/E Ratio24.2
EPS$3.57
Dividend Yield0.03%
Dividend / Share$2.44
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume12.5M
Avg Volume (10D)—
Shares Outstanding1.74B
ABT News
44 articles- Insulet (PODD) Is Down 6.8% After Raising 2026 Guidance And Advancing Closed‑Loop Trial - What's ChangedSimply Wall Street·May 9, 2026
- Pay Less, Gain More: RMD, MDT Top Abbott Laboratories StockTrefis·May 9, 2026
- Abbott Laboratories Stock (ABT) Closed Down by 3.22% on May 8: A Full AnalysisTradingKey·May 8, 2026
- Abbott Laboratories stock hits 52-week low at $86.15 By Investing.comInvesting.com Canada·May 8, 2026
- Abbott's Medical Device Strategy Supports Long-Term Growth OutlookYahoo Finance·May 8, 2026
- Abbott Laboratories Stock: Analyst Estimates & RatingsBarchart·May 8, 2026
- Pregnancy Detection Kits Market Analysis Report 2026 - Competitive Landscape, Opportunities, and Forecasts, 2021-2025 & 2025-2031GlobeNewswire Inc.·May 8, 2026
- Immunoassay Market Competitive Analysis to 2031 | Abbott,openPR.com·May 8, 2026
- Becton Dickinson (BDX) Q2 EPS Loss Tests Bullish Margin Improvement NarrativeSimply Wall Street·May 8, 2026
- Is Abbott Laboratories (ABT) Now Offering Value After Recent Share Price Weakness?Yahoo Finance·May 8, 2026
- What Abbott Laboratories (ABT)'s New AI Cardiac Imaging, Trial Data and Share Plan Mean For ShareholdersSimply Wall Street·May 8, 2026
- Stryker completes acquisition of Amplitude Vascular SystemsMassDevice·May 7, 2026
- Glucotrack Submits Blood Glucose Monitoring Technology to FDAYahoo Finance·May 7, 2026
- Dr Reddy's-Nestlé India JV launches drug to address nutrition gaps and preserving muscle health among diabetic, obesity patients on GLP-1 therapyFortune India·May 7, 2026
- Ivy Parks of BD-Canada Appointed Chair of the Medtech Canada Board of DirectorsYahoo Finance·May 7, 2026
- Cardiogenic Shock Analysis Report 2026: Market to Reach $5.2 Billion by 2030, Driven by Minimally Invasive Techniques, AI Adoption. and Aging PopulationsYahoo Finance·May 7, 2026
- Abbott Cardiac Data Sheds Light On Heart Rhythm Pipeline And Earnings StoryYahoo Finance·May 7, 2026
- Breath Analyzer Analysis Report 2026: Market to More than Double to Reach $4.83 Billion by 2030 with Abbott Laboratories, Lifeloc Technologies, and Intoximeters LeadingYahoo Finance·May 7, 2026
- Lateral Flow Assay Market: 2026 Research Report - AI and Digital Technology Integration to Propel Lateral Flow Assay Market Expansion - Forecast to 2030Yahoo Finance·May 6, 2026
- Got $5,000? These 3 High-Yielding Stocks Are Trading Near Their 52-Week LowsMotley Fool·May 6, 2026
- Timothy P. Walbert Joins Patient Square Capital as a Senior AdvisorYahoo Finance·May 6, 2026
- Abbott Stock Is Trading at 52-Week Lows but Insiders Are Gobbling Up Shares of This Blue-Chip Dividend PayerBarchart·May 5, 2026
- GLP-1 Hydration Products Market Outlook 2036 with Key Contributions from Smoothie King, Liquid I.V., Electrolit, Abbott, Nestlé Health Science, and ADM | Future Market InsightsYahoo Finance·May 5, 2026
- Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on ItYahoo Finance·May 5, 2026
- Agilent Technologies Names Michael Buckner as CLOYahoo Finance·May 4, 2026
- This Dividend King's Yield Hasn't Been This High in a Decade. Is It a Buy?The Motley Fool·May 3, 2026
- 1 Magnificent Dividend Stock Down 30% to Buy and Hold ForeverThe Motley Fool·May 2, 2026
- Abbott Laboratories (ABT) Receives FDA Clearance and CE Mark for Next-Generation Ultreon™ 3.0 SoftwareYahoo Finance·May 1, 2026
- How Investors Are Reacting To Abbott (ABT) Gaining FDA, CE Clearance For AI-Guided Ultreon 3.0Yahoo Finance·Apr 30, 2026
- Jim Cramer Believes “BillionToOne’s a Winner”Yahoo Finance·Apr 30, 2026
- Augment makes first move into $8 trillion distribution sectorYahoo Finance·Apr 29, 2026
- Middle East and Africa Continuous Glucose Monitoring Market Forecast and Company Analysis Report 2026-2034 Featuring Dexcom, Medtronic, Senseonics, Abbott Diabetes Care, and GlySensGlobeNewswire Inc.·Apr 29, 2026
- Dietary Supplements Market Driven by Health and Nutrition DemandGlobeNewswire Inc.·Apr 29, 2026
- Abbott's Strong AFib, Cardiac Device Data Fuels Heart-Rhythm Device BuzzBenzinga·Apr 27, 2026
- Better Medical Device Stock Right Now: Abbott Laboratories vs. DexcomThe Motley Fool·Apr 20, 2026
- China Diabetes Devices Market Forecast and Company Analysis Report 2026-2034 Featuring Roche, Abbott Laboratories, Novo Nordisk, BD, Medtronic, Eli Lilly, and SanofiGlobeNewswire Inc.·Apr 17, 2026
- Why Abbott Laboratories Stock Tumbled on ThursdayThe Motley Fool·Apr 16, 2026
- Could Buying This Dividend Pharma Stock Today Set You Up for Life?The Motley Fool·Apr 10, 2026
- This Pharma Dividend Has Been Raised Every Single Year for Over a DecadeThe Motley Fool·Apr 8, 2026
Price Data
Open$87.55
Previous Close$87.17
Day High$87.69
Day Low$86.35
52 Week High$136.28
52 Week Low$86.15
52-Week Range
$86.15$136.28
$86.30
Fundamentals
Market Cap$150.3B
P/E Ratio24.2
EPS$3.57
Dividend Yield0.03%
Dividend / Share$2.44
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume12.5M
Avg Volume (10D)—
Shares Outstanding1.74B
About Abbott Laboratories
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—